Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 22, 2012

View Archived Issues

Trius Therapeutics synthesizes novel dual-target antibacterial agents

MM-433593 human pharmacokinetic data presented

NEPTUNE I and II data on tamsulosin/solifenacin presented

Ono Pharmaceutical designs novel E-NPP 2 inhibitors

New data on onabotulinumtoxinA reveals benefits on patient-reported outcomes

Further clinical data on dapagliflozin available

Research at Ortho-McNeil-Janssen Pharmaceuticals yields new gamma secretase modulators

Variations in MYH11/NDE1 and MUC16 loci are linked to common epilepsy

Novel candidate anticancer drugs patented

MRC Technology presents new antimalarials

Novel GABA(A) receptor modulators synthesized by team of French researchers

CHMP recommends Bayer's anticoagulant for additional use

Merck Serono to support Auxogyn's fertility test

Tresiba and Ryzodeg receive positive CHMP opinions

Millennium begins phase III MLN-9708 study

A novel derivative of M6G shows analgesic potency

CHMP recommends Abbott's Humira in pediatric Crohn's disease

EMA's CHMP recommends approval of Amyvid

Summit receives second award from the Wellcome Trust for C. difficile antibiotic program

Astellas set to launch Gonax in Japan

BiondVax and MonoSol Rx to collaborate on oral film formulation of universal flu vaccine

Astellas and AIST to collaborate on discovering drugs for neglected tropical diseases

Mirabegron recommended for European approval

TNI BioTech and Hubei Qianjiang Pharmaceuticals to jointly develop anticancer drugs in China

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...